ArticleInternational journal of molecular sciences2025
Global Salivary Proteomic Profiling of Individuals with the Co-Occurrence of Type 2 Diabetes Mellitus, Dyslipidemia, and Periodontitis.
Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Human whole saliva contains informative proteins related to disease processes and is important for oral cavity homeostasis. The aim of this study was to investigate the global salivary proteomic profile, including functional enrichment analysis of individuals affected by combinations of poorly/well-controlled type 2 diabetes mellitus (T2DM), dyslipidemia (DL), and periodontitis (P) for the identification of potential disease biomarkers. Biochemical and periodontal evaluations were performed on 150 subjects divided into five groups according to disease combinations. Unstimulated saliva was collected, and proteomic analysis was performed using Liquid Chromatography Electrospray Ionization Tandem Mass Spectrometry (LC-ESI-MS/MS). Results were obtained by searching for the Homo sapiens database of the UniProt catalog using Proteome Discoverer 1.3. PANTHER GO-Slim (PANTHER version 19.0), and Cytoscape 3.10.1 (extensions Metascape) were used to access biological pathways. A total of 1762 proteins were identified in saliva samples. The proteomic profile of T2DM-DL-P groups (G1-poorly controlled T2DM; G2-well-controlled T2DM) were the most diverse and functionally enriched. In G1 and G3, the most abundant protein was TTN, with ENO-1 being highly enriched and associated with the aerobic glycolysis pathway and PFN1 associated with a pro-inflammatory environment. PFN1 was highly enriched in (G1) AKIRIN-2 (immune response), and in (G2) KMT2A (epigenetic regulation) and CALML3 (DNA metabolism and repair). For (G4), the highest abundant protein was RIMS-1, with VIRMA (cytoskeletal organization) being the most enriched. The global salivary proteomics analyses demonstrated significantly altered protein profiles in each group of different pathological combinations, providing new insights into their biology and identifying potential diagnostic and therapeutic candidates for these diseases of growing global concern.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.